HMGA2 and pancreatic adenocarcinoma: The activation of TGF-β signaling induced by HMGA2 was shown to occur preferentially at the invasive front of colorectal tumors and in secondary metastatic lesions [35], and in lymph node metastasis of pancreatic adenocarcinoma [36].